Home Health Admissions Growth
Admissions increased by 8.1% from Q4 to Q1, with fee-for-service growing 4% sequentially. Year-over-year admission growth was up 0.7% and normalized growth was 2.5%.
Growth in Non-Medicare Revenue
Non-Medicare admissions increased by 7.4% year-over-year, driven by payer innovation contracts. Non-Medicare revenue per visit improved by 7.6% year-over-year.
Hospice Segment Performance
Total admissions grew 8% year-over-year with 5.2% same-store growth. Census grew by 12.3% with 10.6% same-store growth.
Cost Efficiency Improvements
Cost per day decreased by 0.8% year-over-year and 2.7% sequentially in the hospice segment. Completed transition to outsourced coding resource expected to save $1.5 million for 2025.
Financial Performance
Home health segment EBITDA improved by 7.9% sequentially. Hospice segment EBITDA grew by 65% year-over-year. Q1 2025 leverage ratio improved to 4.4x.
Balance Sheet and Cash Flow
Generated approximately $17 million of free cash flow and reduced overall bank debt by $25 million in the quarter.